89 related articles for article (PubMed ID: 22863762)
21. Impact of CT attenuation correction by SPECT/CT in brain perfusion images.
Ishii K; Hanaoka K; Okada M; Kumano S; Komeya Y; Tsuchiya N; Hosono M; Murakami T
Ann Nucl Med; 2012 Apr; 26(3):241-7. PubMed ID: 22278350
[TBL] [Abstract][Full Text] [Related]
22. Quantification of pulmonary blood flow (PBF): validation of perfusion MRI and nonlinear contrast agent (CA) dose correction with H(2)15O positron emission tomography (PET).
Neeb D; Kunz RP; Ley S; Szábo G; Strauss LG; Kauczor HU; Kreitner KF; Schreiber LM
Magn Reson Med; 2009 Aug; 62(2):476-87. PubMed ID: 19488992
[TBL] [Abstract][Full Text] [Related]
23. Can (18)F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer?
Ul-Hassan F; Simo R; Guerrero-Urbano T; Oakley R; Jeannon JP; Cook GJ
Clin Nucl Med; 2013 Apr; 38(4):263-5. PubMed ID: 23429398
[TBL] [Abstract][Full Text] [Related]
24. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
[TBL] [Abstract][Full Text] [Related]
25. Parametric imaging of myocardial blood flow with 15O-water and PET using the basis function method.
Watabe H; Jino H; Kawachi N; Teramoto N; Hayashi T; Ohta Y; Iida H
J Nucl Med; 2005 Jul; 46(7):1219-24. PubMed ID: 16000292
[TBL] [Abstract][Full Text] [Related]
26. [Usefulness of 18F-FDG PET/CT examination in the diagnosis of head and neck cancer--preliminary results].
Kuźmińska M; Osuch-Wójcikiewicz E; Fronczewska-Wieniawska K; Królicki L; Niemczyk K
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):17-21. PubMed ID: 22000246
[TBL] [Abstract][Full Text] [Related]
27. Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation.
Wang K; Heron DE; Clump DA; Flickinger JC; Kubicek GJ; Rwigema JC; Ferris RL; Ohr JP; Quinn AE; Ozhasoglu C; Branstetter BF
Radiother Oncol; 2013 Jan; 106(1):90-5. PubMed ID: 23333021
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
Inubushi M; Saga T; Koizumi M; Takagi R; Hasegawa A; Koto M; Wakatuki M; Morikawa T; Yoshikawa K; Tanimoto K; Fukumura T; Yamada S; Kamada T
Ann Nucl Med; 2013 Jan; 27(1):1-10. PubMed ID: 22914968
[TBL] [Abstract][Full Text] [Related]
29. Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors.
Hirasawa S; Tsushima Y; Takei H; Hirasawa H; Taketomi-Takahashi A; Takano A; Oriuchi N; Endo K
Acad Radiol; 2007 Mar; 14(3):312-8. PubMed ID: 17307664
[TBL] [Abstract][Full Text] [Related]
30. Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?
Akagunduz OO; Savas R; Yalman D; Kocacelebi K; Esassolak M
Nucl Med Biol; 2015 Nov; 42(11):899-904. PubMed ID: 26275933
[TBL] [Abstract][Full Text] [Related]
31. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
[TBL] [Abstract][Full Text] [Related]
32. Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Coleman RE
Radiology; 2007 Jul; 244(1):263-72. PubMed ID: 17495174
[TBL] [Abstract][Full Text] [Related]
33. Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck.
Burri RJ; Rangaswamy B; Kostakoglu L; Hoch B; Genden EM; Som PM; Kao J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):682-8. PubMed ID: 18258379
[TBL] [Abstract][Full Text] [Related]
34. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
35. A preliminary report on the impact of ¹⁸F-FDG PET/CT in the management of paediatric head and neck cancer.
Boktor RR; Omar WS; Mousa E; Attia I; Refaat A; Eltawdy MH; Pitman AG; Abdel-Dayem HM
Nucl Med Commun; 2012 Jan; 33(1):21-8. PubMed ID: 21968431
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.
Grosu AL; Souvatzoglou M; Röper B; Dobritz M; Wiedenmann N; Jacob V; Wester HJ; Reischl G; Machulla HJ; Schwaiger M; Molls M; Piert M
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):541-51. PubMed ID: 17869667
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients.
Seith F; Gatidis S; Schmidt H; Bezrukov I; la Fougère C; Nikolaou K; Pfannenberg C; Schwenzer N
Invest Radiol; 2016 Jan; 51(1):66-71. PubMed ID: 26348596
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical non-commercial tools for automated quantification of myocardial blood flow using oxygen-15-labelled water PET/CT.
Harms HJ; Nesterov SV; Han C; Danad I; Leonora R; Raijmakers PG; Lammertsma AA; Knuuti J; Knaapen P
Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):431-41. PubMed ID: 24107905
[TBL] [Abstract][Full Text] [Related]
40. PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
Lindholm P; Sutinen E; Oikonen V; Mattila K; Tarkkanen M; Kallajoki M; Aro H; Böhling T; Kivioja A; Elomaa I; Minn H
Nucl Med Biol; 2011 Feb; 38(2):295-300. PubMed ID: 21315286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
